A Case Study in Personalized Medicine: Rilpivirine Versus Efavirenz for Treatment-Naive HIV Patients

Wei Liu, Zhiwei Zhang, Lei Nie, Guoxing Soon

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1381-1392
Number of pages12
JournalJournal of the American Statistical Association
Volume112
Issue number520
DOIs
StatePublished - Oct 2 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Statistics and Probability
  • Statistics, Probability and Uncertainty

Keywords

  • G-computation
  • Individualized treatment rule
  • Inverse probability weighting
  • Optimal treatment regime
  • Treatment effect heterogeneity
  • Treatment selection

Cite this